• Views: in the last
  • 23Week
  • 14Month
  • 191Total


  • NJ A1824
  • Requires health care practitioners to inform patients of addiction potential of controlled dangerous substances prior to issuing prescription.
Introduced
(1/27/2016)
In Committee
(1/27/2016)
Crossed OverPassedSignedDead/Failed/Vetoed
2016-2017 Regular Session
This bill would require that, prior to issuing a prescription for a controlled dangerous substance which is a prescription drug, a practitioner must inform the patient, or the patient's parent or guardian if the patient is under 18 years of age, of the risks of developing a physical or psychological dependence on the controlled dangerous substance.
Health and Senior Services
Introduced, Referred to Assembly Health and Senior Services Committee  (on 1/27/2016)
 
 
Date Chamber Action Description
1/27/2016 A Introduced, Referred to Assembly Health and Senior Services Committee
Date Motion Yea Nay Other
None specified